Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $33.3200 (-0.4%) ($33.3200 - $33.4600) on Thu. May. 25, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.35% (three month average) | RSI | 62 | Latest Price | $33.3200(-0.4%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | HALO advances 3% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IFRA(40%) IWO(37%) IWM(36%) IWN(34%) SDY(34%) | Factors Impacting HALO price | HALO will decline at least -1.675% in a week (0% probabilities). UUP(-13%) TBT(-11%) IGOV(-9%) BNDX(-8%) IPO(-7%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.675% (StdDev 3.35%) | Hourly BBV | -0.6 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $33.95(-1.86%) | 10 Day Moving Average | $33.69(-1.1%) | 20 Day Moving Average | $32.85(1.43%) | To recent high | -31.4% | To recent low | 10.5% | Market Cap | $4.554b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |